BrainCells raises $30M for neuroregeneration drugs
See our story about this San Diego drug developer in today’s briefing at VentureBeat LifeScience.
Next Story: Zoho launches HR app for smaller companies
Previous Story: Aridis Pharma seeks $10M for oral-form drugs and vaccines
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.